Hervana Bio

Non-hormonal Female Contraceptive Technology Offering Protection Against STIs

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem Founded 2008
Total raised
$1.1M
Stage
Pre-Funding
Founded
2008
Headcount
2
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Hervana Bio is a biopharmaceutical company that develops womens health products. The company has developed a female contraceptive platform technology that is non-hormonal and offers protection against sexually transmitted infections. Hervanas LJ-102 is a highly effective, long-lasting contraceptive technology free from the drawbacks of current hormone-based contraceptives. The products safety profile and prolonged action enable greater compliance and accessibility, particularly in populations where the available methods of contraception are contraindicated, undesirable, or socially unacceptable. In 2012, Hervana Bio received a $1 million grant from the Bill and Melinda Gates Foundation.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2B2C

Highlights

1 Patents

Tags

pregnancybiotechnologywomen-healthpharmaceuticalswomenfemtech